Sickle cell mutation has been reported in polymorphic frequencies in several Eastern Mediterranean countries, including Iraq. In Iraq, sickle cell disorders cluster in the south and the extreme north of the country. 7 In the latter, most cases are registered in a single center in the Kurdish Province of Duhok. 8 Studies on Kurds revealed that SCD is generally of moderate severity, with patients less likely to have acute chest syndromes, sepsis, stroke, and leg ulcers, compared to their African counterparts. 9 Other than studies from Saudi Arabia, little is known about the contribution of QTL to HbF and disease phenotypes in SCD in the Eastern Mediterranean region. [10] [11] [12] Studying QTLs in ethnically distinct populations with SCD is important and will help identify possible functional motifs responsible for HbF levels and F-cell numbers. 13 In the current study, the first from Iraq, we attempted to determine the minor allele frequencies of SNPs in the three QTL regions and to assess their relative contributions to HbF variability and clinical phenotypes in SCD patients,
with the hope that this may help predict severity and possible complications and thus guide early management options.
| MATERIAL S AND ME THODS

| Patients
A total of 128 patients registered at the inherited blood disorders center in Duhok were recruited. The patients were molecularly confirmed cases of sickle cell disease (including 104 with HbSS and 24 with sickle/β 0 -thalassemia). The inclusion criteria included age ≥ 4 years, confirmed diagnosis of SCD, and a stable state at the time of enrollment, as defined by no history of acute events related to sickle cell disease for at least 4 weeks. Patients who were on hydroxyurea were excluded, so were cases with sickle/β + -thalassemia.
The study was approved by the ethics committee at the College of Medicine, University of Duhok, Iraq, and informed consent was obtained from all patients or their guardians.
| Methods
All patients had a detailed history and examination, as well as a thorough review of records. In addition to demographic data, was used for all statistical evaluations, and P < 0.05 was considered significant. Among the five SNPs investigated, multiple linear regression revealed that only three were significant, namely HBG2 rs7482144, BCL11A rs1427407, and HMIP rs9399137, and F I G U R E 1 Box plots showing the distribution of HbF% according to the number of minor alleles in each of the five SNPs studied, among 128 SCD Iraqi Kurd patients enrolled. The lower right box plot is for the cumulative no. of minor alleles in the three significant SNPs. The P value shown in the upper right corner of each box plot has been calculated by Kruskal-Wallis test contributed, respectively, 18.1%, 13.4%, and 8.8% to HbF variability (Table 2) .
| RE SULTS
Clinical and laboratory correlations with various SNPs revealed that among carriers of the minor alleles at HBG2 rs7482144, hemoglobin (Hb) was higher (P = 0.033), while LDH, transfusions, pain, reticulocyte count, platelets, and leukocytes were lower (P < 0.0005, <0.0005, 0.029, 0.006, 0.012, and <0.0005, respectively). On the other hand, BCL11A rs1427407 minor allele carriers had higher Hb (P = 0.019) and lower reticulocytes, LDH, transfusion, and pain frequencies (P = 0.016, 0.019, 0.003, and 0.029, respectively). While in relevance to HMIP rs9399137 minor allele carriers, Hb was higher (P = 0.028), leukocytes and transfusion frequencies were lower (P = 0.017 and 0.020, respectively). Interestingly, and in contrast to the three former SNPs, BCL11A rs10189857 minor alleles were associated with lower Hb, higher LDH, and reticulocytes (P = 0.019, 0.019, and 0.026, respectively). No significant correlations were found between any of the variables and minor alleles in HMIP rs28384513.
When the cumulative number of minor alleles in the three significant SNPs (rs7481244, rs1427407, and rs9399137) was evaluated, it was found that both HbF% and Hb increased with increasing numbers of minor alleles (P < 0.0005 and 0.004, respectively), while LDH, reticulocytes, leukocytes, transfusion, and pain frequencies decreased with such an increase (P = 0.003, 0.004, <0.0005, <0.0005, and 0.017, respectively) ( Figure 2 ; Figure S1 ).
| D ISCUSS I ON
The current study has revealed that each of the three major QTLs (Table 3) . [18] [19] [20] [21] [22] Similar to current study, the minor allele at rs7482144 was found to be significantly associated with higher 
F I G U R E 2 Box plots showing the annual frequencies of pain (A) and transfusion sessions (B)
relevant to the cumulative number of minor alleles in the significant three SNPs (rs7482144, rs1427407, and rs9399137)
The second most important contributor to HbF variability in the current study was rs1427407 in the second intron of the trans-acting element BCL11A on chromosome 2p. BCL11A is a major regulator of Hb switching and HbF. 14, 25, 26 The MAF of this SNP in the current study is 0.266, which is similar to that reported among African
Americans, and is intermediate between the lower rates reported in
Indian patients to the higher rates reported in Saudi Arabians with SCD (Table 3) . 12, 27 This SNP accounted for 13.4% of HbF variability among our Kurdish SCD patients. Similarly, this SNP was found to contribute significantly to HbF variability in several SCD populations including Indians (23%), Eastern Saudi Arabians (7.5%), Cameroonians (6.3%), Southern Brazilian, and African Americans. 11, 15, 24, 27, 28 The third most important contributor to HbF variability documented in the current study was rs9399137 at HMIP locus on chromosome 6q.
This SNP is known to be in linkage disequilibrium with rs66650371, a 3 bp deletion at HMIP, which has been reported as the most significant motif accounting for HMIP modulation of HbF. [29] [30] [31] [32] It is located near the erythroid-specific DNase I hypersensitivity site 2 within HMIP block 2, in close proximity to the binding sites for erythropoiesisrelated transcription factors TAL1, E47, GATA2, and RUNX1. 13 In the present study, MAF of rs9399137 is 0.137, which is among the highest frequencies observed in SCD populations (Table 3 ). This SNP has been reported to be associated with HbF levels in other populations, including Indian, African American, Cameroonian, Tanzanian, British, and Eastern and Southern Brazilian patients, 15, 19, 20, 24, 28, 33 but not in Saudi Arabian or North Brazilian SCD patients. 10, 11, 23 The current study has revealed that carriers of the minor alleles of each of rs7482144, rs1427407, and rs9399137 had significantly higher hemoglobin and lower transfusion requirements.
Furthermore, minor alleles of former two were also associated with lower reticulocyte counts and annual pain frequencies. These observations support the milder SCD phenotype in minor allele carriers compared to noncarriers. This is likely to be a consequence of the significantly higher HbF in carriers that has been found to have an inverse relationship with the frequency of pain episodes in SCD as reported by several investigators. 15, 18, 34 These findings could be explained by the inhibitory effect of HbF on deoxy-HbS polymerization (which in turn is the major driver of the pathophysiology of this disease). 35 These observations were to a great extent similar to those reported in Indian SCD patients, where it was found that carriers of the minor allele of rs7482144 had a milder disease with higher hemoglobin and HbF, and lower transfusion and pain crises frequencies. 36, 37 Moreover, Sheehan et al 38 demonstrated
that minor alleles at rs1427407 were associated with higher Hb and lower pain frequencies compared to noncarriers. While Lettre et al 15 failed to find a significant association between pain episodes frequencies and individual SNP that they studied (including rs7482144 and rs9399137), they did find an inverse correlation between HbF and pain frequency. Wonkam et al also failed to find an association between rs9399137 and hospital admission or vaso-occlusive event rates in Cameroonian SCD patients, which they attributed to the low frequency of the minor alleles in the population.
18,24
In contrast to the three above-discussed SNPs, minor alleles of BCL11A rs10189857 and HMIP rs28384513 had been associated with a lower HbF as observed in several populations. 15, 16, 19, 24 However, their contributions to HbF variability in the latter studies were limited. In the present study, rs10189857 had a similar negative correlation with HbF, but not when multiple linear regression was applied. HMIP rs28384513, on the other hand, was not significantly associated with HbF or with disease severity.
Both latter observations are not unique and have been reported by others. 16, 38 In the current study, we also attempted to determine whether there are additive effects of the three significant HbF modulating have an independent BCL11A effect), to generate a single quantitative variable they labeled "g(HbF)" among British SCD patients. 39, 40 The latter could predict HbF in SCD and was linked to lower hospitalization rates and higher Hb. This is to a great extent consistent with our own observations, since the additive effect of three of the four proposed SNPs was also demonstrated by the present study.
In conclusion, the study has revealed that SNPs in all three 
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